Results 81 to 90 of about 284,262 (205)

The differences of fibrinogen levels in various types of hemorrhagic transformations

open access: yesFrontiers in Neurology
IntroductionHemorrhagic transformation (HT) is a serious complication that can occur spontaneously after an acute ischemic stroke (AIS) or after a thrombolytic/mechanical thrombectomy.
Jingfang Long   +10 more
doaj   +1 more source

Misdiagnosis of hereditary amyloidosis as AL (Primary) amyloidosis [PDF]

open access: yes, 2002
Background: Hereditary, autosomal dominant amyloidosis, caused by mutations in the genes encoding transthyretin, fibrinogen A -chain, lysozyme, or apolipoprotein A-I, is thought to be extremely rare and is not routinely included in the differential ...
Booth, D.R.   +7 more
core  

Serum fibrinogen is not elevated in patients with myasthenia gravis

open access: yesScientific Reports
Myasthenia gravis (MG) is an autoimmune, autoantibody-mediated disease characterized by fatigable weakness of skeletal muscles. MG is a heterogeneous disease that currently lacks a robust biomarker for diagnosing all subtypes.
Taylor A. Bauman   +8 more
doaj   +1 more source

Three-dimensional Migration of Neurites Is Mediated by Adhesion Site Density and Affinity [PDF]

open access: yes, 2000
Three-dimensional neurite outgrowth rates within fibrin matrices that contained variable amounts of RGD peptides were shown to depend on adhesion site density and affinity. Bi-domain peptides with a factor XIIIa substrate in one domain and a RGD sequence
Hubbell, Jeffrey A., Schense, Jason C.
core  

Different effects of oral and transdermal hormone replacement therapies on Factor IX, APC resistance, t-PA, PAI and C- reactive protein - a cross-sectional population survey [PDF]

open access: yes, 2001
The effects of hormone replacement therapy (HRT) on thrombosis risk, thrombotic variables, and the inflammatory marker C- reactive protein (CRP) may vary by route of administration (oral versus transdermal).
Lowe, G.D.O.   +5 more
core  

Acquired hypofibrinogenemia: current perspectives

open access: yesJournal of Blood Medicine, 2016
Martin W Besser,1 Stephen G MacDonald2 1Department of Haematology, 2Department of Specialist Haemostasis, The Pathology Partnership, Addenbrooke’s Hospital, Cambridge, UK Abstract: Acquired hypofibrinogenemia is most frequently caused by ...
Besser MW, MacDonald SG
doaj  

Fibrinogen replacement to prevent intracranial hemorrhage in ischemic stroke patients after thrombolysis – a prospective randomized open blinded endpoint trial (FibER): rationale and methods

open access: yesJournal of Stroke and Cerebrovascular Diseases
Rationale: Fibrinogen depletion happens soon after intravenous thrombolysis (IVT) for acute ischemic stroke, in relation to the suboptimal affinity of recombinant tissue plasminogen activator (rtPA) to thrombus fibrin.
Andrea Zini   +11 more
doaj   +1 more source

Effects of transporting bulls at different space allowances on physiological, haematological and immunological responses to a 12-h journey by road [PDF]

open access: yes, 2006
peer-reviewedThe effects of space allowance during transportation on physiological, haematological and immunological responses in nine-month old bulls (250 kg) were assessed before and after a 12-h road journey.
Earley, Bernadette, O'Riordan, Edward G.
core  

Diagnostic and Predictive Recurrence Value of Plasma Fibrinogen in Patients With Adrenocortical Carcinoma

open access: yesClinical Medicine Insights: Oncology
Background: The correlation between fibrinogen levels and adrenocortical carcinoma (ACC) remains unclear. This study aimed to explore the value of preoperative plasma fibrinogen as a biomarker for ACC.
Chengquan Ma, Bin Yang, Quanzong Mao
doaj   +1 more source

Electrospun Fibrinogen-Polydioxanone Composite Matrix: Potential for In Situ Urologic Tissue Engineering [PDF]

open access: yesJournal of Engineered Fibers and Fabrics, 2008
Our objective is to demonstrate an electrospun fibrinogen-PDO (polydioxanone) composite scaffold will retain the superior cellular interaction of fibrinogen while producing a product with the functional strength needed for direct implantation. Fibrinogen-
Michael C. McManus, M.D.   +5 more
doaj  

Home - About - Disclaimer - Privacy